Peptide Initiative

Peptides · Peptide comparison

Capromorelin vs MK-677 (Ibutamoren)

An oral ghrelin agonist originally developed by Pfizer that stimulates growth hormone and appetite. FDA-approved for veterinary use (Entyce and Elura) and investigated in human trials for age-related muscle wasting and appetite support.

The oral growth hormone secretagogue that tricks your body into producing more GH — no needles required.

  • Growth Hormone
  • Growth Hormone

At a glance

Quick comparison

Dose rangeCapromorelin10–10 mgMK-677 (Ibutamoren)25–25 mg
FrequencyCapromorelinOnce dailyMK-677 (Ibutamoren)Once daily
AdministrationCapromorelinOral (capsule or tablet)MK-677 (Ibutamoren)Oral (capsule or liquid)
Cycle lengthCapromorelin4-6 weeksMK-677 (Ibutamoren)8-12 weeks
Onset speedCapromorelinModerate (1-2 weeks)MK-677 (Ibutamoren)Moderate (1-2 weeks)
Evidence levelCapromorelinModerate human trials (Phase 1-2)MK-677 (Ibutamoren)Moderate human trials (Phase 1-2)

Efficacy

Benefit ratings

GH & IGF-1 Stimulation

Capromorelin88%
MK-677 (Ibutamoren)No recorded rating

Physical Function

Capromorelin82%
MK-677 (Ibutamoren)No recorded rating

Oral Convenience

Capromorelin92%
MK-677 (Ibutamoren)No recorded rating

Muscle and body composition

CapromorelinNo recorded rating
MK-677 (Ibutamoren)85%

Recovery and athletic performance

CapromorelinNo recorded rating
MK-677 (Ibutamoren)80%

Sleep quality and metabolic health

CapromorelinNo recorded rating
MK-677 (Ibutamoren)75%

Technical data

Compound specifications

Capromorelin

Molecular formula
C28H35N5O4
Molecular weight
505.6 g/mol
Half-life
About 1.2 hours in dogs (ENTYCE label)
Bioavailability
44% oral in dogs and 65% in rats; no human figure published on this page
CAS number
193273-66-4

MK-677 (Ibutamoren)

Molecular formula
C27H36N4O5S
Molecular weight
528.7 g/mol
Half-life
4-6 hours (IGF-1 elevation persists ~24 hours)
Bioavailability
High oral bioavailability
CAS number
159634-47-6

Protocols

Dosing compared

Capromorelin

Oral

  • 3 mgTwice daily · Initial weeksOne of the lower doses tested in the year-long study in older adults; raised growth hormone and IGF-1 [1].
  • 10 mgOnce daily at bedtime · OngoingA simple once-daily bedtime dose used in the human trial that improved lean body mass [1].
  • 10 mgTwice daily · Up to 12 months in the trialThe highest daily amount studied in older adults (20 mg/day). The trial reported results for the pooled treatment groups, not the largest gains for this dose [1].

MK-677 (Ibutamoren)

Oral

  • Weeks 2-410 mgOnce daily · 2-4 weeks initialLower entry dose used in practice to limit water retention and appetite surge before titrating up.
  • Studied up to 1-2 years25 mgOnce daily · Studied up to 1-2 years25 mg once-daily oral is the dose used in the randomized trial in healthy older adults; increased GH/IGF-1 and fat-free mass [1]. Most-studied dose [2].

Applications

Best suited for

Capromorelin

Age-Related Muscle Wasting
Capromorelin showed significant improvements in physical function — including tandem walk and stair climb — in elderly adults, making it a strong candidate for combating sarcopenia.
Appetite Stimulation
As an FDA-approved veterinary appetite stimulant, capromorelin has extensive real-world evidence for boosting food intake and body weight in mammals.
Growth Hormone Research
One of the best-studied oral ghrelin agonists with human Phase 2 data, offering researchers a well-characterized tool for studying GH/IGF-1 pathways.

MK-677 (Ibutamoren)

Older Adults (60+) Seeking Body Composition Improvements
MK-677 was designed for aging populations. It restores GH and IGF-1 to youthful levels, [7] increases lean mass, and improves physical function in people over 60. A 2-year clinical trial showed a 1.1 kg gain in fat-free mass [1] with only modest fat gain—ideal for maintaining strength in older age.
Athletes and Fitness Enthusiasts Wanting Recovery Support
Oral dosing makes MK-677 convenient for athletes. It enhances muscle protein synthesis, speeds recovery after intense training, and supports lean mass building without the hassle of injections.
People with Chronic Wasting or Protein Deficiency
Clinical trials show MK-677 helps treat protein-energy wasting in kidney disease and other conditions. [2] It stimulates appetite (a feature in these populations) and preserves muscle tissue—making it useful for those losing mass despite good nutrition.

Safety profile

Side effects

Capromorelin

Common

  • Appetite stimulation
  • Fluid retention and weight gain

Uncommon

  • Joint and muscle aches
  • Fatigue or lethargy
  • Peripheral edema (swelling)

Serious

  • Hyperglycemia

MK-677 (Ibutamoren)

Common

  • Increased appetite
  • Mild water retention or edema
  • Elevated fasting glucose

Uncommon

  • Joint or muscle pain
  • Carpal tunnel syndrome or nerve compression symptoms
  • Mild nausea or digestive upset

Serious

  • Glucose dysregulation and diabetes risk

Research status

Safety & evidence

Capromorelin

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Not approved for human use. FDA-approved for veterinary use only: ENTYCE (appetite stimulation in dogs, 2016) and ELURA (weight loss in cats with chronic kidney disease, 2020); both labels state "not for use in humans".
Safety overview
Capromorelin was generally well-tolerated in Phase 2 human trials involving nearly 400 elderly participants. Most side effects were mild to moderate. Its FDA-approved veterinary use provides additional long-term safety data in mammalian species.

Contraindications

  • Active cancer or history of cancer (GH may stimulate growth)
  • Uncontrolled diabetes or severe metabolic disorders
  • Severe liver or kidney disease
  • Pregnancy and lactation

MK-677 (Ibutamoren)

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
MK-677 has been studied in hundreds of humans over 2+ years and is generally well tolerated. [1][3] Most side effects are mild and manageable, especially with lower starting doses. The lack of injection requirement makes it safer than injectable GH in terms of infection risk and sterility concerns. However, it is not FDA approved and should be viewed as a research compound.

Contraindications

  • Uncontrolled diabetes or severe glucose dysregulation
  • Active cancer or high cancer risk requiring caution with IGF-1 elevation
  • Pregnancy or breastfeeding

Decision guide

Which is right for you?

Capromorelin

Choose Capromorelin if…

  • Stimulating growth hormone production in elderly adults
  • Supporting appetite and weight gain in wasting conditions
  • Improving muscle mass and physical performance
  • Anti-aging and longevity optimization

MK-677 (Ibutamoren)

Choose MK-677 (Ibutamoren) if…

  • Building lean muscle mass and strength
  • Improving overall body composition in aging adults
  • Enhancing athletic recovery and performance
  • Supporting metabolic health and fat loss